Here is a report on recent news and commentary related to the Federal Circuit and its cases. Today’s report highlights:
- an article about the Federal Circuit denying a request for a rehearing in a case about whether “an artificial intelligence program” may be named an inventor; and
- another article about “[a] congressional push to let drug companies patent diagnostic tests and other biotech inventions” and its potential impact.